Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug
In short: The family of drugs used to make Ozempic and Mounjaro will be removed from Australia's compounding exemptions, stopping pharmacies from making off-brand replicas.Compounding…
